Literature DB >> 32951085

Experimental and theoretical characterization of the strong effects on DNA stability caused by half-sandwich Ru(II) and Ir(III) bearing thiabendazole complexes.

Javier Santolaya1,2, Natalia Busto3, Marta Martínez-Alonso1,4, Gustavo Espino1, Jörg Grunenberg5, Giampaolo Barone2, Begoña García1.   

Abstract

The synthesis and characterization of two half-sandwich complexes of Ru(II) and Ir(III) with thiabendazole as ancillary ligand and their DNA binding ability were investigated using experimental and computational methods. 1H NMR and acid-base studies have shown that aquo-complexes are the reactive species. Kinetic studies show that both complexes bind covalently to DNA through the metal site and non covalently through the ancillary ligand. Thermal stability studies, viscosity, circular dichroism measurements and quantum chemical calculations have shown that the covalent binding causes breaking of the H-bonding between base pairs, bringing about DNA denaturation and compaction. Additionally, molecular dynamics (MD) simulations and quantum mechanics/molecular mechanics (QM/MM) calculations shed light into the binding features of the Ru(II) and Ir(III) complexes and their respective enantiomers toward double-helical DNA, highlighting the important role played by the NˆN ancillary ligand once the complexes are covalently linked to DNA. Moreover, metal quantification in the nucleus of SW480 colon adenocarcinoma cells were carried out by inductively coupled plasma-mass spectrometry (ICP-MS), both complexes are more internalized than cisplatin after 4 h of exposition. However, in spite of the dramatic changes in the helicity of the DNA secondary structure induced by these complexes and their nuclear localization, antiproliferative studies have revealed that both, Ru(II) and Ir(III) complexes, cannot be considered cytotoxic. This unexpected behavior can be justified by the fast formation of aquo-complexes, which may react with components of the cell culture medium or the cytoplasm compartment in such a way that they may become deactivated before reaching DNA.

Entities:  

Keywords:  DNA destabilization; Half-sandwich; Iridium(III); Ruthenium(II); Thiabendazole

Mesh:

Substances:

Year:  2020        PMID: 32951085     DOI: 10.1007/s00775-020-01823-x

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  35 in total

1.  Thiabendazole, a well-known antifungal drug, exhibits anti-metastatic melanoma B16F10 activity via inhibiting VEGF expression and inducing apoptosis.

Authors:  Jinnan Zhang; Conghai Zhao; Yufei Gao; Yang Jiang; Huaxin Liang; Gang Zhao
Journal:  Pharmazie       Date:  2013-12       Impact factor: 1.267

2.  Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.

Authors:  Haimei Chen; John A Parkinson; Simon Parsons; Robert A Coxall; Robert O Gould; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

3.  Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.

Authors:  Cristina Pérez-Arnaiz; María Isabel Acuña; Natalia Busto; Igor Echevarría; Marta Martínez-Alonso; Gustavo Espino; Begoña García; Fernando Domínguez
Journal:  Eur J Med Chem       Date:  2018-08-02       Impact factor: 6.514

4.  Organometallic half-sandwich iridium anticancer complexes.

Authors:  Zhe Liu; Abraha Habtemariam; Ana M Pizarro; Sally A Fletcher; Anna Kisova; Oldrich Vrana; Luca Salassa; Pieter C A Bruijnincx; Guy J Clarkson; Viktor Brabec; Peter J Sadler
Journal:  J Med Chem       Date:  2011-03-28       Impact factor: 7.446

Review 5.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

6.  Sex difference in the nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.

Authors:  T Mizutani; K Yoshida; K Ito; S Kawazoe
Journal:  Food Chem Toxicol       Date:  1992-03       Impact factor: 6.023

7.  Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.

Authors:  Tidarat Nhukeaw; Khwanjira Hongthong; Paul J Dyson; Adisorn Ratanaphan
Journal:  Apoptosis       Date:  2019-08       Impact factor: 4.677

Review 8.  Molecular mechanisms of cisplatin resistance.

Authors:  L Galluzzi; L Senovilla; I Vitale; J Michels; I Martins; O Kepp; M Castedo; G Kroemer
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

9.  Half-sandwich Ru(η6-p-cymene) complexes featuring pyrazole appended ligands: Synthesis, DNA binding and in vitro cytotoxicity.

Authors:  Yen-Chung Huang; Jebiti Haribabu; Ching-Ming Chien; Gopal Sabapathi; Chon-Kit Chou; Ramasamy Karvembu; Ponnambalam Venuvanalingam; Wei-Min Ching; Ming-Li Tsai; Sodio C N Hsu
Journal:  J Inorg Biochem       Date:  2019-02-23       Impact factor: 4.155

10.  Chronic oral toxicity and carcinogenicity study of thiabendazole in rats.

Authors:  T Fujii; H Mikuriya; M Sasaki
Journal:  Food Chem Toxicol       Date:  1991-11       Impact factor: 6.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.